| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |